Fast Company Writer and Producer John Converse Townsend got microchipped back in October 2017. He's now had the smart chip inside his body for three months and explains the capabilities and opportunity behind this new technology.
"It's been fun," says Townsend. "I do have it programmed currently to call my girlfriend." Townsend explains he can tap his phone to the chip to then make a phone call. In the future he says the chip could be used to make mobile payments.
The chip can be compared to the size of a Basmati rice grain. Townsend got the idea to test out a microchip after interviewing Wisconsin-based Three Square Market who has offered to microchip their employees.
Apple warned of a potential $8 billion future sales hit due to supply issues, but Dan Ives, the managing director of equity research at Wedbush Securities, noted that the record quarterly report the tech giant posted shows demand remains high for Apple products and services. Ives joined Cheddar to explain why investors should look past the warning. "In these types of markets where many are yelling fire in a crowded theater, you look at the demand trends because that continues to be the focus for Apple," he said "I think you combine that with the services. I view it as a defensive name. It's a Rock of Gibraltar stock in a Category 5 storm as well as also an offensive play as I believe we start to move out of some of these just brutal headwinds that we've been seeing in the market once the Fed rips the band-aid off."
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
Airbnb will allow its employees to live and work almost anywhere around the world, fully embracing a remote work policy to attract staff and ensure flexibility.
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
